{
    "2020-08-21": [
        [
            {
                "time": "",
                "original_text": "FIDELITY INVESTMENT TRUST增持泰格医药(03347)49.12万股，每股作价110.1534港元",
                "features": {
                    "keywords": [
                        "FIDELITY INVESTMENT TRUST",
                        "增持",
                        "泰格医药",
                        "港股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物板块回撤-10%，哪些医药基金更抗跌？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "板块回撤",
                        "抗跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347.HK)获FIDELITY INVESTMENT TRUST增持49.12万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "FIDELITY INVESTMENT TRUST",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "相对陌生但又颇具前景的CRO行业",
                "features": {
                    "keywords": [
                        "CRO行业",
                        "前景"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}